AdimrSC-2f Completed Phase 1 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT04522089A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine